RANKL Inhibition by Osteoprotegerin Prevents Bone Loss Without Affecting Local or Systemic Inflammation Parameters in Two Rat Arthritis Models: Comparison With Anti-TNFα or Anti-Il-1 Therapies
Arthritis Research and Therapy - United Kingdom
doi 10.1186/ar2879
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2009
Authors
Publisher
Springer Science and Business Media LLC